OneVentures
Team Portfolio Funds Entrepreneurs Blog News Investors
TeamPortfolioFundsEntrepreneursBlogNewsInvestors
OneVentures

Nanopatch vaccine technology company attracts $25 million

 
Learn More
 
University of QueenslandCarolyn MillerFebruary 10, 2015Vaxxas, Paul Kelly
Twitter LinkedIn0 0 Likes
Previous

Investors keen on biotech injection: OneVentures

The AustralianCarolyn MillerFebruary 11, 2015OneVentures, Paul Kelly, Anne-Marie Birkill, Michelle Deaker
Next

A company developing needle-free vaccination tech just raised $25 million

Business InsiderCarolyn MillerFebruary 10, 2015Vaxxas

Suite 13.02, 179 Elizabeth Street, Sydney NSW 2000

enquiries@one-ventures.com

+61 2 8205 7379

Disclaimer

Responsible Investment Policy

Privacy Policy

 
 
OneVentures Pty Ltd
179 Elizabeth Street (Suite 13.02),
Sydney, NSW, 2000,
Australia
+61 2 8205 7379 enquiries@one-ventures.com
Hours

Copyright © 2017 OneVentures Pty Ltd